Mast Cell Tryptase Promotes Airway Remodeling by Inducing Anti-Apoptotic and Cell Growth Properties in Human Alveolar and Bronchial Epithelial Cells.

PAR-2 airway remodeling alveolar epithelium anti-apoptosis bronchial epithelium cell growth growth factors mast cell proteases tryptase

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
22 05 2023
Historique:
received: 26 02 2023
revised: 12 05 2023
accepted: 18 05 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 6 7 2023
Statut: epublish

Résumé

Bronchial and alveolar remodeling and impaired epithelial function are characteristics of chronic respiratory diseases. In these patients, an increased number of mast cells (MCs) positive for serine proteases, tryptase and chymase, infiltrate the epithelium and alveolar parenchyma. However, little is known regarding the implication of intraepithelial MCs on the local environment, such as epithelial cell function and properties. In this study, we investigated whether MC tryptase is involved in bronchial and alveolar remodeling and the mechanisms of regulation during inflammation. Using novel holographic live cell imaging, we found that MC tryptase enhanced human bronchial and alveolar epithelial cell growth and shortened the cell division intervals. The elevated cell growth induced by tryptase remained in a pro-inflammatory state. Tryptase also increased the expression of the anti-apoptotic protein BIRC3, as well as growth factor release in epithelial cells. Thus, our data imply that the intraepithelial and alveolar MC release of tryptase may play a critical role in disturbing bronchial epithelial and alveolar homeostasis by altering cell growth-death regulation.

Identifiants

pubmed: 37408273
pii: cells12101439
doi: 10.3390/cells12101439
pmc: PMC10217033
pii:
doi:

Substances chimiques

Tryptases EC 3.4.21.59

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Curr Protoc Neurosci. 2016 Oct 3;77:9.54.1-9.54.10
pubmed: 27696362
Ther Adv Respir Dis. 2009 Jun;3(3):113-29
pubmed: 19638369
Clin Sci (Lond). 2009 Dec 23;118(7):439-50
pubmed: 20025610
Respir Res. 2011 Oct 20;12:139
pubmed: 22014187
J Appl Physiol (1985). 2001 Sep;91(3):1372-9
pubmed: 11509538
Thorax. 2010 Jul;65(7):626-32
pubmed: 20627922
Int J Mol Sci. 2021 May 16;22(10):
pubmed: 34065716
Front Immunol. 2020 Jun 18;11:1134
pubmed: 32625205
J Pathol. 2005 May;206(1):28-38
pubmed: 15772985
Allergy. 2020 Dec;75(12):3195-3207
pubmed: 32578219
Chest. 2013 Sep;144(3):1026-1032
pubmed: 24008953
Cell Death Differ. 2012 Jan;19(1):67-74
pubmed: 22075983
Thorax. 2014 Mar;69(3):240-6
pubmed: 24127021
Allergy. 2011 Dec;66(12):1590-7
pubmed: 21958156
BMC Pulm Med. 2022 Mar 14;22(1):86
pubmed: 35287655
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15072-7
pubmed: 12397176
Curr Opin Immunol. 2007 Dec;19(6):676-80
pubmed: 17720466
Nat Med. 2010 Mar;16(3):273-4
pubmed: 20208514
J Allergy Clin Immunol. 2022 Dec;150(6):1534-1544
pubmed: 35779668
Front Cell Dev Biol. 2020 Apr 02;8:223
pubmed: 32300593
Am J Respir Crit Care Med. 2010 Feb 1;181(3):206-17
pubmed: 19926870
Cells. 2022 Sep 18;11(18):
pubmed: 36139491
Am J Respir Crit Care Med. 2005 Mar 1;171(5):431-9
pubmed: 15563633
Int Arch Allergy Immunol. 1997 Sep;114(1):1-9
pubmed: 9303324
J Histochem Cytochem. 2014 Oct;62(10):698-738
pubmed: 25062998
Cell. 1986 Jul 18;46(2):155-69
pubmed: 3013421
Cell Adh Migr. 2021 Dec;15(1):202-214
pubmed: 34308764
Front Pharmacol. 2020 Feb 14;11:47
pubmed: 32116722
Cell Biosci. 2021 Jan 07;11(1):8
pubmed: 33413657
Curr Opin Pulm Med. 2014 Jan;20(1):23-30
pubmed: 24296687
Front Immunol. 2014 Nov 14;5:569
pubmed: 25452755
Eur Respir J. 2022 Aug 4;60(2):
pubmed: 35027395
J Allergy Clin Immunol. 2006 Jun;117(6):1277-84
pubmed: 16750987
Am J Respir Crit Care Med. 2011 Feb 1;183(3):299-309
pubmed: 20813890
J Clin Invest. 1990 Oct;86(4):1055-64
pubmed: 2170444
Curr Opin Pulm Med. 2016 Jan;22(1):10-7
pubmed: 26574723
Expert Opin Ther Targets. 2009 Nov;13(11):1333-45
pubmed: 19793002
Front Immunol. 2017 Apr 12;8:424
pubmed: 28446910
Clin Exp Allergy. 2018 Mar;48(3):266-277
pubmed: 29336501
Cell Commun Signal. 2018 Sep 15;16(1):59
pubmed: 30219079
Nat Rev Dis Primers. 2015 Sep 10;1:15025
pubmed: 27189668
Respir Med. 2023 Apr-May;210:107168
pubmed: 36822489
Allergy. 2022 Dec;77(12):3538-3552
pubmed: 35950646
J Immunol. 1996 Jan 1;156(1):275-83
pubmed: 8598474
J Allergy Clin Immunol. 2023 Jul;152(1):107-116.e4
pubmed: 36907566
J Clin Invest. 2019 Nov 1;129(11):4979-4991
pubmed: 31437129
Respir Med. 2019 Sep;156:33-46
pubmed: 31421589

Auteurs

Frida Berlin (F)

Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.

Sofia Mogren (S)

Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.

Camilla Ly (C)

Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.

Sangeetha Ramu (S)

Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.

Morten Hvidtfeldt (M)

Department of Respiratory Medicine, Copenhagen University Hospital Bispebjerg, 2400 Copenhagen, Denmark.

Lena Uller (L)

Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.

Celeste Porsbjerg (C)

Department of Respiratory Medicine, Copenhagen University Hospital Bispebjerg, 2400 Copenhagen, Denmark.

Cecilia K Andersson (CK)

Department of Experimental Medical Science, Lund University, 22184 Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH